Literature DB >> 9737588

SIV-associated nephropathy in rhesus macaques infected with lymphocyte-tropic SIVmac239.

V H Gattone1, C Tian, W Zhuge, M Sahni, O Narayan, E B Stephens.   

Abstract

We examined the renal pathology and viral genetic changes following inoculation of six rhesus macaques with lymphocyte-tropic SIVmac239. Portions of the renal cortex were sieved into glomerular and tubulointerstitial (TI) fractions and examined for SIVmac sequences by PCR and for p27 core antigen. SIVmac sequences were detected in renal tissue from five of six macaques (three of five glomerular and five of five TI fractions were positive for SIV by PCR). Glomerulosclerosis (segmental and global) was evident in two macaques that were positive for env sequences in the glomerular fractions. Diffuse mesangial hyperplasia and matrix expansion were present in all three animals with glomerular SIV, as was an increase in glomerular collagen I and collagen IV. Tubulointerstitial inflammation was evident in all virus-inoculated macaques. The TI infiltration of CD68+ cells was most pronounced in the animals with SIVmac present in the glomerulus. All SIVmac-infected macaques exhibited increased glomerular deposition of IgM and to a lesser extent IgG, but no C3 or IgA was evident. Sequence analyses of the viral env gene (gp120) isolated from the glomerular and TI fractions of a macaque that developed glomerulopathy revealed the presence of specific viral variants in glomerular and TI fractions. In addition, chimeric viruses constructed with glomerular but not tubulointerstitial gp120 sequences were converted to a macrophage-tropic phenotype. These results indicate that infection by lymphocyte-tropic SIVmac239 is primarily associated with immunoglobulin deposition in the glomerulus and suggests that when glomerulosclerosis develops there is selection of viral variants that are macrophage tropic in nature.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737588     DOI: 10.1089/aid.1998.14.1163

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  7 in total

1.  Expression of simian immunodeficiency virus nef in immune cells of transgenic mice leads to a severe AIDS-like disease.

Authors:  Marie-Chantal Simard; Pavel Chrobak; Denis G Kay; Zaher Hanna; Serge Jothy; Paul Jolicoeur
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Urogenital Lesions in Nonhuman Primates at 2 National Primate Research Centers.

Authors:  Shannon Kirejczyk; Christopher Pinelli; Olga Gonzalez; Shyamesh Kumar; Edward Dick; Sanjeev Gumber
Journal:  Vet Pathol       Date:  2020-11-19       Impact factor: 2.221

Review 3.  [Virus associated glomerulonephritis].

Authors:  H L Tillmann; A Schwarz
Journal:  Internist (Berl)       Date:  2003-09       Impact factor: 0.743

4.  Rhesus macaques infected with macrophage-tropic simian immunodeficiency virus (SIVmacR71/17E) exhibit extensive focal segmental and global glomerulosclerosis.

Authors:  E B Stephens; C Tian; Z Li; O Narayan; V H Gattone
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

5.  Mutations in the highly conserved SLQYLA motif of Vif in a simian-human immunodeficiency virus result in a less pathogenic virus and are associated with G-to-A mutations in the viral genome.

Authors:  Kimberly Schmitt; M Sarah Hill; Autumn Ruiz; Nathan Culley; David M Pinson; Scott W Wong; Edward B Stephens
Journal:  Virology       Date:  2008-11-21       Impact factor: 3.616

6.  Clinical monitoring and correlates of nephropathy in SIV-infected macaques during high-dose antiretroviral therapy.

Authors:  Brigitte E Sanders-Beer; Yvette Y Spano; Dawn Golighty; Abigail Lara; Diane Hebblewaite; Lourdes Nieves-Duran; Lowrey Rhodes; Keith G Mansfield
Journal:  AIDS Res Ther       Date:  2011-01-21       Impact factor: 2.250

Review 7.  Research Relevant Conditions and Pathology in Nonhuman Primates.

Authors:  Chandra Saravanan; Thierry Flandre; Carolyn L Hodo; Anne D Lewis; Lars Mecklenburg; Annette Romeike; Oliver C Turner; Hsi-Yu Yen
Journal:  ILAR J       Date:  2020-12-31       Impact factor: 1.521

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.